Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

KALA BIO, Inc. (27F0.F)

2.6120
0.0000
(0.00%)
As of April 23 at 2:34:35 PM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
--
3,892
11,240
Cost of Revenue
--
--
--
2,560
4,097
Gross Profit
--
--
--
1,332
7,143
Operating Expense
34,235
34,235
34,328
82,688
116,576
Operating Income
-34,235
-34,235
-34,328
-81,356
-109,433
Net Non Operating Interest Income Expense
-3,727
-3,727
-3,103
-6,602
-8,276
Other Income Expense
-549
-549
-4,768
43,136
-24,896
Pretax Income
-38,511
-38,511
-42,199
-44,822
-142,605
Net Income Common Stockholders
-38,511
-38,511
-42,199
-44,822
-142,605
Diluted NI Available to Com Stockholders
-38,511
-38,511
-42,199
-44,822
-142,605
Basic EPS
-10.15
--
-17.35
-29.48
-108.32
Diluted EPS
-10.15
--
-17.35
-29.48
-108.32
Basic Average Shares
3,796.0470
--
2,432.0080
1,520.6110
1,316.4950
Diluted Average Shares
3,796.0470
--
2,432.0080
1,520.6110
1,316.4950
Total Operating Income as Reported
-40,983
-40,983
-39,663
-81,706
-130,245
Total Expenses
34,235
34,235
34,328
85,248
120,673
Net Income from Continuing & Discontinued Operation
-38,511
-38,511
-42,199
-44,822
-142,605
Normalized Income
-37,962
-37,962
-41,689
-88,884
-116,398
Interest Income
2,056
2,056
2,711
664
104
Interest Expense
5,783
5,783
5,814
7,266
8,380
Net Interest Income
-3,727
-3,727
-3,103
-6,602
-8,276
EBIT
-32,728
-32,728
-36,385
-37,556
-134,225
EBITDA
-32,469
-32,469
-36,082
-37,019
-133,250
Reconciled Cost of Revenue
--
--
--
2,560
4,097
Reconciled Depreciation
259
259
303
537
975
Net Income from Continuing Operation Net Minority Interest
-38,511
-38,511
-42,199
-44,822
-142,605
Total Unusual Items Excluding Goodwill
-549
-549
-510
44,062
-26,207
Total Unusual Items
-549
-549
-510
44,062
-26,207
Normalized EBITDA
-31,920
-31,920
-35,572
-81,081
-107,043
12/31/2021 - 7/26/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ONCT Oncternal Therapeutics, Inc.
0.5266
-24.12%
 
ACOG Alpha Cognition Inc. Common Stock
4.9200
+7.89%
 
LPTX Leap Therapeutics, Inc.
0.3950
+2.33%
 
SPRB Spruce Biosciences, Inc.
0.1329
+2.55%
 
MREO Mereo BioPharma Group plc
2.5600
+2.40%
 
SWTX SpringWorks Therapeutics, Inc.
41.21
+1.75%
 
APVO Aptevo Therapeutics Inc.
0.7400
+6.72%
 
IOVA Iovance Biotherapeutics, Inc.
3.1900
-0.62%
 
VKTX Viking Therapeutics, Inc.
25.79
+1.22%